share_log

T2 Biosystems | EFFECT: Others

SEC announcement ·  Jun 5 18:06
Summary by Futu AI
T2 Biosystems, a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on June 3, 2024. The notice, bearing the Accession Number 0001213900-24-046256, indicates that the company's submission of form POS AM has been officially accepted and is now effective. The SEC's approval is a significant regulatory milestone for T2 Biosystems, which is identified by the CIK number 0001885408 and had previously filed under the number 333-262835.
T2 Biosystems, a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on June 3, 2024. The notice, bearing the Accession Number 0001213900-24-046256, indicates that the company's submission of form POS AM has been officially accepted and is now effective. The SEC's approval is a significant regulatory milestone for T2 Biosystems, which is identified by the CIK number 0001885408 and had previously filed under the number 333-262835.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.